Amphibian-Derived Peptides Show Promise for Skin Wound Healing, Modulating Inflammation and Angiogenesis
Background
Effective therapies for skin wound healing remain a critical clinical need, as injuries compromise the body's primary barrier, leading to infection, delayed recovery, and pathological scarring. Current treatments often fall short in addressing the complex, multi-stage healing process. Amphibian-derived peptides (ADPs) have garnered significant interest due to their diverse bioactivities, extending beyond their well-known antimicrobial properties to directly influence various phases of wound repair.
Study Design
This comprehensive review synthesized current knowledge on amphibian-derived peptides, analyzing their discovery, distribution, biological activities, and mechanisms in wound healing. The authors assessed the strength of existing evidence, discussed recent findings, and identified major translational challenges. They also proposed strategies to improve peptide developability, including rational structural modification, biomaterial-based delivery systems, and translation-oriented preclinical evaluation.
Results
Amphibian-derived peptides demonstrate multifaceted roles in wound healing, extending beyond their antimicrobial effects. They are shown to regulate multiple stages of healing by modulating inflammation, promoting keratinocyte and fibroblast migration and proliferation, enhancing angiogenesis, and supporting extracellular matrix (ECM) remodeling. Key mechanisms involve interactions with various cellular pathways, though specific mechanistic validation is often insufficient for many candidates. The review highlighted significant translational challenges, including peptide instability, potential toxicity, and difficulties in formulation and delivery. It also noted the limited use of clinically relevant wound models in preclinical studies, hindering direct translation. Strategies like structural modification and biomaterial-based delivery systems were discussed as potential solutions to these hurdles.
Amphibian-derived peptides are a valuable source of multifunctional wound-healing agents, but their clinical development requires stronger mechanistic evidence, standardized efficacy assessment, and better translational design.
Key Findings
- Amphibian-derived peptides regulate inflammation, promote keratinocyte/fibroblast migration/proliferation, enhance angiogenesis, and support ECM remodeling.
- These peptides offer multifunctional wound-healing properties beyond their known antimicrobial effects.
- Translational challenges include peptide instability, toxicity, and difficulties in formulation and delivery.
- Insufficient mechanistic validation and limited use of clinically relevant wound models hinder clinical development.
- Strategies like structural modification and biomaterial-based delivery systems are proposed to improve developability.
Why It Matters
This review underscores the significant potential of amphibian-derived peptides as a novel class of therapeutics for skin wound repair, offering a pathway to overcome limitations of current treatments. For biohackers and clinicians, it highlights the broad biological activities of these peptides, suggesting future protocols might incorporate agents that simultaneously target infection, inflammation, and tissue regeneration. The emphasis on improving peptide stability and delivery, potentially via biomaterial systems, indicates that future formulations could offer enhanced efficacy and user convenience. Developing these peptides into usable protocols will require robust preclinical validation in clinically relevant models and advanced delivery methods.
wound-healing
skin-repair
amphibian-peptides
antimicrobial
inflammation
angiogenesis